Max Healthcare Institute Ltd (MAXHEALTH) AI Stock Analysis

• Market Cap: ₹1.13T
• Dividend Yield: 0.13%
• Average Volume (3M): 53.96K
• Price to Earnings (P/E): 99.4
• Beta (1Y): 1.34
• Revenue Growth: 32.65%
• EPS Growth: 8.86%
• Country: IN
• Employees: 19,500
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 3.15
• Shares Outstanding: 972,236,450
• 10 Day Avg. Volume: 65,074
• 30 Day Avg. Volume: 53,960
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹1,289.50
• Price Target Upside: 11.08% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 6

• Rating: 55 Neutral
• Price Target: ₹1,212.00 ▲(4.41% Upside)

Max Healthcare Institute Ltd's overall stock score is primarily influenced by its strong financial performance, which is offset by bearish technical indicators and a high valuation. The lack of earnings call data and corporate events means these factors do not impact the score.

Max Healthcare Institute Ltd Business Overview & Revenue Model

Company Description

Max Healthcare Institute Limited provides healthcare services in India. It offers services in various specialties, including cancer care/oncology, cardiac sciences, neuro sciences, liver transplant and biliary sciences, orthopaedics, nephrology, kidney transplant, bone marrow transplant, bariatric/weight loss surgery, minimal access/laparoscopic surgery, urology, gastroenterology, and aesthetic and reconstructive surgery. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. As of August 27, 2021, it operated a network of 17 healthcare facilities, including tertiary and quaternary care hospitals at Saket, Patparganj, Vaishali, Rajendra Place, and Shalimar Bagh in Delhi National Capital Region; one each in Mumbai, Mohali, Bathinda, and Dehradun; a secondary care hospital in Gurugram; and day care centres at Noida, Lajpat Nagar, and Panchsheel Park in Delhi National Capital Region and one in Mohali, Punjab. The company is based in Gurugram, India.

How the Company Makes Money

Max Healthcare Institute Ltd generates revenue through its extensive network of hospitals and clinics, offering a variety of healthcare services. The primary revenue stream comes from patient services, including inpatient and outpatient care, diagnostic services, and surgical procedures. The company also earns money through specialized healthcare services such as oncology, cardiology, neurology, and orthopedics. Additionally, Max Healthcare may engage in partnerships with insurance providers to offer cashless treatment options, thereby attracting a larger patient base. Revenue is also derived from pharmacy sales, laboratory services, and preventive health check-ups, contributing to the company's overall earnings.

Max Healthcare Institute Ltd Financial Statement Overview

Summary

Max Healthcare Institute Ltd exhibits a strong financial position with consistent revenue growth and profitability. The balance sheet remains stable with moderate leverage, and cash flow generation is robust. However, there is room for improvement in operating efficiency and debt levels.

Income Statement

Max Healthcare Institute Ltd has demonstrated impressive growth in revenue, with a consistent upward trajectory over the years. The company achieved a Gross Profit Margin of 62.3% and a Net Profit Margin of 15.3% in the latest year, reflecting strong profitability. The EBIT Margin is also noteworthy at 41.3%, indicating efficient management of operating expenses. However, the EBITDA Margin at 25.6% suggests room for improvement in operating efficiency.

Balance Sheet

The company's balance sheet showcases a strong equity position with an Equity Ratio of 61.6%. The Debt-to-Equity Ratio of 0.32 reflects prudent financial leverage, which is a positive sign in maintaining financial stability. ROE is robust at 11.5%, indicating effective utilization of equity to generate profits. However, the increase in total debt over the years warrants monitoring for potential risks.

Cash Flow

Max Healthcare Institute Ltd has shown a commendable Free Cash Flow Growth Rate of 44%, indicating enhanced cash generation capabilities. The Operating Cash Flow to Net Income Ratio of 1.36 demonstrates healthy cash flow relative to net income. The Free Cash Flow to Net Income Ratio of 0.46 suggests that the company is generating sufficient free cash flow to support its net income, though there is room for improvement.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	70.28B	70.28B	54.06B	45.63B	38.83B	24.82B
Gross Profit	38.39B	43.77B	33.53B	36.41B	29.60B	18.88B
EBITDA	18.61B	18.01B	16.70B	13.80B	10.61B	2.85B
Net Income	10.76B	10.76B	10.58B	11.04B	6.05B	-1.38B
Balance Sheet
Total Assets	152.14B	152.14B	120.00B	101.02B	91.89B	85.44B
Cash, Cash Equivalents and Short-Term Investments	6.82B	6.82B	9.80B	14.99B	4.86B	6.27B
Total Debt	30.10B	30.10B	15.08B	6.89B	11.33B	13.25B
Total Liabilities	58.34B	58.34B	35.92B	26.92B	29.07B	29.06B
Stockholders Equity	93.81B	93.81B	84.08B	74.10B	62.82B	56.39B
Cash Flow
Free Cash Flow	0.00	4.94B	3.43B	8.74B	1.87B	-5.60M
Operating Cash Flow	0.00	14.59B	11.22B	12.09B	7.48B	1.18B
Investing Cash Flow	0.00	-16.32B	-12.85B	-11.87B	-7.72B	-730.00M
Financing Cash Flow	0.00	-1.64B	-2.64B	-2.89B	-2.94B	1.91B

Max Healthcare Institute Ltd Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1160.85
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MAXHEALTH, the sentiment is Negative. The current price of 1160.85 is below the 20-day moving average (MA) of 1172.72, below the 50-day MA of 1218.52, and above the 200-day MA of 1144.85, indicating a neutral trend. The MACD of -15.89 indicates Negative momentum. The RSI at 42.47 is Neutral, neither overbought nor oversold. The STOCH value of 41.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MAXHEALTH.

Max Healthcare Institute Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FORTIS	75 Outperform	720.72B	84.16	8.68%	0.10%	14.04%	32.99%
MEDANTA	75 Outperform	363.97B	68.76	14.22%	0.04%	15.42%	10.66%
APOLLOHOSP	73 Outperform	1.12T	71.74	17.61%	0.24%	14.31%	51.71%
KIMS	71 Outperform	297.80B	79.10	17.99%	―	24.71%	19.17%
NH	65 Neutral	363.35B	46.31	21.79%	0.25%	12.09%	-2.79%
MAXHEALTH	55 Neutral	₹1.13T	99.40		0.13%	32.65%	8.86%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Max Healthcare Institute Ltd Corporate Events

Max Healthcare Announces Virtual AGM and Final Dividend for FY 2025

Max Healthcare Institute Ltd has announced the details of its 24th Annual General Meeting (AGM), which will be held virtually on July 31, 2025. The company has provided information on e-voting procedures for shareholders to participate in decision-making processes. Additionally, the Board of Directors has approved a final dividend payment of ₹1.50 per equity share for the financial year ended March 31, 2025, highlighting the company’s commitment to returning value to its shareholders.

Max Healthcare Announces Dividend Record Date and Tax Deduction Process

Max Healthcare Institute Ltd has announced the record date for its final dividend for the financial year 2024-25 as July 4, 2025, with the dividend subject to approval at the upcoming Annual General Meeting on July 30, 2025. The company has communicated to its members about the tax deduction process on the dividend, reflecting changes in tax regulations, which now require members to pay tax on dividend income rather than the company.

Max Healthcare Announces AGM and Dividend Details

Max Healthcare Institute Ltd has announced its 24th Annual General Meeting (AGM) scheduled for July 30, 2025, to be held via video conference. The company has set July 4, 2025, as the record date for determining shareholders eligible for a final dividend of Rs. 1.50 per share for the financial year 2024-25, pending AGM approval. In line with the Finance Act 2020, the company will deduct tax at source on dividends, with rates varying based on the shareholder’s residency status and documentation provided. This announcement underscores Max Healthcare’s compliance with regulatory requirements and its commitment to shareholder returns.